The Latest SPAC News and Rumors: January 31, 2022

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Byju in negotiations with at least three SPACs, MSP Recovery’s LifeWallet announces new data, and Hiro Metaverse SPAC plans London IPO

Byju’s Aim for SPAC Merger Agreement Within a Month

India’s most valuable startup, the online education provider Byju’s, is in negotiations with at least three SPACs and is aiming to unveil plans to go public via a merger with one of them in three to four weeks, according to people familiar with the matter.

The SPACs include Michael Klein’s Churchill Capital (NYSE:CCV) and Michael Dell’s MSD Acquisition Corp. (NASDAQ:MSDA). An additional contender is Harry Sloan, a long-time Hollywood executive who has since become a prolific SPAC investor. A fourth, Altimeter Capital Management (NASDAQ:AGC), is conducting due diligence ahead of any potential offer.

MSP Recovery’s LifeWallet Announces Data of More Than 1 Million Patients Uploaded to Platform Less Than A Month Since Launch 

MSP Recovery, LLC, a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, that in July agreed to a business combination with Lionheart Acquisition Corporation II (Nasdaq: LCAPU) today announced that since releasing LifeWallet Powered by MSP Recovery less than a month ago, the data of more than 1 million patients has been uploaded onto the LifeWallet platform in partnership with leading healthcare providers.

Hiro Metaverse SPAC plans London IPO, Eyes UK Video Games Industry

Hiro Metaverse Acquisitions said on Monday it plans to raise up to 115 million pounds ($154.38 million) by listing itself on the London Stock Exchange, as the blank-check company looks to tap into the video games and metaverse industries in the UK.

The SPAC intends to focus on targets in the video games, e-sports, interactive streaming and metaverse technologies sectors, among others, with business operations in the United Kingdom, Europe or Israel.

GreenLight BioSciences and Germains Seed Technology Partner to Explore Development of World’s First dsRNA Seed Treatment to Control Pests

GreenLight Biosciences and Germains Seed Technology, an industry leader in seed treatment technologies, today announced a research partnership agreement that could lead to the first commercial use of RNA as a seed treatment to control crop diseases and offer options to farmers looking for innovative solutions.

In August 2021, GreenLight Biosciences announced plans to become publicly listed through a business combination with Environmental Impact Acquisition Corp. (Nasdaq: ENVI).